Success Story: Our Firm Helped a Postdoctoral Associate Achieve Fast-Track NIW Success
Client’s Testimonial:
“Thanks again for the smooth processing of the I-140 application.”
On January 25th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Molecular Neuroscience (Approval Notice).
General Field: Molecular Neuroscience
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: Nepal
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: January 25th, 2025
Processing Time: 2 months, 4 days
Case Summary:
“Considering [Client’s] remarkable ability to uncover the genetic mechanisms underlying pathophysiology, as well as the overall caliber of his research, it is more than apparent that he is operating at the top of our field. Therefore, it is in our field’s collective interest that [Client] is permitted to continue conducting research in the United States.”
The statement above comes from one of the four recommendation letters submitted as part of our client’s I-140 National Interest Waiver (NIW) petition. With guidance from the North America Immigration Law Group (NAILG), the case was successfully approved, recognizing the substantial merit and national importance of the client’s research.
Advancing Gene Therapy for Neurological Diseases
Holding a Ph.D. in cell and molecular biology, the client specializes in molecular neuroscience and is conducting advanced research aimed at developing gene therapy tools to better understand molecular and genetic mechanisms that drive neurological and neurodegenerative diseases. The focus of this research is to identify novel therapeutic targets and disease-modifying agents for a range of conditions, including autism, Alzheimer’s disease, vascular cognitive impairment, and dementia.
In the current work, the client applies innovative molecular techniques to investigate how genetic factors influence brain and vascular function. This research bridges cutting-edge gene therapy technology and clinical neuroscience, offering promising directions for developing targeted treatments for cognitive and neurodevelopmental disorders that have long lacked effective therapies.
Demonstrating Scientific Excellence and Influence
In support of the petition, we highlighted the client’s strong publication record, which includes three peer-reviewed journal articles (two of them first-authored), one first-authored conference abstract, and two preprints (one first-authored). The client’s scholarly contributions have been cited 19 times, underscoring the growing impact of the research in the scientific community.
The petition also documented the client’s role in nationally funded projects, with research supported by the National Institutes of Health (NIH) and the U.S. Department of Defense (DoD), two premier funding institutions that prioritize work advancing public health and national security. Such recognition demonstrates that the client’s research is both credible and essential to the advancement of U.S. biomedical innovation.
A Nationally Significant Endeavor
Through the NIW petition, our team at NAILG established that the client’s education, expertise, and research record have well-positioned the client to advance this nationally significant endeavor.
Ultimately, the client’s NIW petition was approved, confirming both the exceptional quality of the scientific record and the importance of continuing this groundbreaking work in the United States. We are honored to have supported this talented molecular neuroscientist and look forward to the continued impact of this research in advancing treatments for neurological and neurodegenerative diseases.